Definition
Gross-to-Net
Gross-to-net is the difference between a drug's gross sales at list price and the net revenue the manufacturer keeps after rebates, discounts, chargebacks, fees and other price concessions.
2 min readReviewed September 14, 2026
Also known as: GTN, Gross-to-net discount, Gross-to-net bubble, Gross-to-net deductions
What is gross-to-net?
Manufacturers book gross sales at Wholesale Acquisition Cost (WAC), the list price charged to wholesalers. Much of that amount never becomes revenue: it flows back to payers, pharmacy benefit managers, government programs, wholesalers and patients through a series of deductions.
The deductions are usually expressed in dollars or as a percentage of gross sales, often called the gross-to-net discount. For heavily rebated brands in competitive classes, net price can be a small fraction of list price, while drugs with little competition often have a much smaller gap.
Manufacturers must estimate many deductions before the actual invoices and claims arrive, so they record reserves that are adjusted later as data come in.
Common gross-to-net deductions
Typical line items include:
- Commercial rebates and administrative fees paid to pharmacy benefit managers and health plans.
- Medicaid Drug Rebate Program rebates, including inflation-based additional rebates.
- 340B Drug Pricing Program discounts, typically settled through wholesaler chargebacks.
- Medicare Part D manufacturer discounts and Medicare inflation rebates.
- Federal discounts, including Federal Supply Schedule pricing and TRICARE retail pharmacy refunds.
- Wholesaler fees, prompt pay discounts, group purchasing contract chargebacks and product returns.
- Copay coupons and other patient support costs.
Why gross-to-net matters
Gross-to-net explains why list price trends can mislead. A manufacturer can raise WAC every year while net price stays flat or falls, and the widening gap across the industry has been called the gross-to-net bubble.
For pricing analysts, forecasting net revenue means modeling channel mix: the same drug earns very different net prices in commercial, Medicaid, Medicare, 340B and federal channels. For investors and consultants, gross-to-net assumptions can matter more to a brand forecast than volume. For policy analysts, the size of the gap is central to debates about list price transparency, rebate pass-through and patient cost sharing.
Common misconceptions about net price
Net price is not a single public number. Manufacturer financial reports usually disclose gross-to-net totals at the company or product level, not by customer, and public benchmarks capture only some concessions. Average Sales Price (ASP), for example, excludes Medicaid rebates and 340B sales, so it is not the same as average net price across all channels.